Login
← Go Back
Ipca Laboratories
IPCALAB · Pharma > Pharmaceuticals & Drugs · Chairman: Premchand Godha · MD: Premchand Godha · Listing date: Oct. 24, 1994 · Employees: 14574 · Mumbai · http://www.ipca.com
Stock Price vs Company Growth
1d
2.9%
1w
2.1%
1m
2.1%
3m
1.3%
6m
7.9%
1y
4.0%
5y
9.5%
10y
18.0%
all
19.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,475 2.9%
1,363
1,582
Company Overview
Sales
9,357 Cr
Growth: 12.4%
Profit after Tax
832 Cr
Growth: 6.8%
Large Cap
37,432 Cr
P/E: 45.0x
Industry P/E: 29.7x
Fundamentals
Sales (Cr) ₹ 9,357
Growth 12.4%
EBITDA 19.8%
P/S 4.0x
Dividend 0.3%
P/E 45.0x
Book Value ₹ 294
PEG Ratio 3.6x
ROE 11.6%
P/B 5.0x
Shareholding Pattern
Institutions
Dsp Midcap Fund
4.58 %
Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund
3.1 %
L And T Mutual Fund Trustee Ltd-L And T Mid Cap Fund
2.32 %
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
2.19 %
Hdfc Life Insurance Company Limited
2.02 %
Promoters
Kaygee Investments Pvt. Ltd.
21.47 %
Kaygee Laboratories Pvt. Ltd.
6.61 %
Chandurkar Investments Pvt. Ltd.
5.5 %
Paschim Chemicals Pvt. Ltd.
4.0 %
Premchand Godha
2.29 %
Others
Iepf
0.29 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Services and productsAPI- Ipca produces various APIs at its production facilities. Its core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness in a dynamic market. Ipca has also emerged as one of India’s top exporters of APIs, serving in many countries around the globe.
Belongs to (27 Indices) view more
Investors (98)
mexin.me...
icici.pr...
axis.mut...
Followers (11)
keerthi
nitin2
deepak